[ORGANIZATION]
Replimune
Featured in 2 tracked stories · first seen
Situations
AI-driven viral genome design research
2 clusters · 18 sources · last updated
Latest: Stanford researchers use generative AI to design functional new viruses
Researchers in the United States are increasingly utilizing generative artificial intelligence and advanced computational models to design novel viral genetic sequences. Initial developments at the Arc Institute involve
Replimune melanoma therapy FDA approval
3 clusters · 18 sources · last updated
Latest: FDA approves new oncolytic viral therapy for anti‑PD‑1‑refractory melanoma
Following the FDA’s Cellular, Tissue and Gene Therapies Advisory Committee vote of 10‑3 in late July 2026, the agency granted accelerated approval on 6 August 2026 to Replimune’s oncolytic herpes‑virus therapy RP1, marke